BCV
DFTX

Banque Cantonale Vaudoise’s Definium Therapeutics DFTX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-66
Closed -$1K – 917
2024
Q2 		$1K Buy
+66
New +$577 ﹤0.01% 983
2022
Q2 		– Sell
-51
Closed -$1K – 1324
2022
Q1 		$1K Hold
51
– – ﹤0.01% 1283
2021
Q4 		$1K Hold
51
– – ﹤0.01% 1308
2021
Q3 		$2K Buy
+51
New +$2.21K ﹤0.01% 1256

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banque Cantonale Vaudoise's DFTX Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Definium Therapeutics (DFTX) in Q3 2024, closing a stake of 66 shares — an estimated $1K sold.

Banque Cantonale Vaudoise first reported a position in DFTX in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 157 funds tracked by Wall St. Rank hold DFTX as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining Definium Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 66 Definium Therapeutics shares in Q3 2024, an estimated $1K.
  • Banque Cantonale Vaudoise first reported a position in Definium Therapeutics in Q3 2021 and held it in 4 quarters.
  • Banque Cantonale Vaudoise's Definium Therapeutics position peaked at $2K in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.